Biased? Add real quotes to replace AI-generated perspectives. Read more.

Should we spend $24 billion to have prototype vaccines ready for each of the 26 known viral families that cause human disease?

Cast your vote:
Results (16):
  • would disagree and say according to AI:
    I believe that allocating $24 billion to develop prototype vaccines for every known viral family is an inefficient use of resources. This approach spreads our efforts too thin and assumes that all viruses pose an equal threat, which isn't the case. We should prioritize funding for targeted vaccine research and development based on the severity and probability of viral outbreaks, as well as invest in broad-spectrum antiviral treatments and better healthcare infrastructure.
    Info
    Delegate
  • would strongly disagree and say according to AI:
    Spending $24 billion on prototype vaccines is not the most effective use of our resources. Instead, we should focus on addressing the root causes of epidemics, such as poverty, lack of access to healthcare, and environmental degradation. Health equity and systemic changes are far more impactful in the long run.
    Info
    Delegate
  • would abstain and say according to AI:
    While creating prototype vaccines for known viral families is a commendable goal, it's essential to weigh the significant financial investment against other urgent needs. We must consider how best to allocate resources to protect public health effectively.
    Info
    Delegate
  • would agree and say according to AI:
    Spending $24 billion to develop prototype vaccines for the 26 known viral families is a proactive and essential investment in public health. By preparing in advance, we can significantly reduce the time needed to respond to future pandemics, ultimately saving countless lives and reducing the economic impact of outbreaks. Foreseeing potential threats and being prepared is key to global health security.
    Info
    Delegate
  • would agree and say according to AI:
    Investing $24 billion to have prototype vaccines ready for each of the 26 known viral families is a strategic and forward-thinking move. The lessons from the COVID-19 pandemic have shown us the immense value of preparedness. This investment could not only save countless lives but also stabilize economies and prevent future global disruptions.
    Info
    Delegate
  • would agree and say according to AI:
    Investing $24 billion in developing prototype vaccines for the 26 known viral families is a proactive and essential step. This advance preparation can save countless lives and economic costs by allowing us to respond swiftly to future pandemics. The COVID-19 pandemic has shown us the critical importance of being prepared.
    Info
    Delegate
  • would agree and say according to AI:
    Investing $24 billion to develop prototype vaccines for all 26 viral families that cause human disease is a critical step in protecting public health. By being proactive, we can prevent future pandemics and save countless lives. This investment not only safeguards our health but also strengthens our economy by reducing the long-term costs associated with disease outbreaks.
    Info
    Delegate
  • would strongly agree and say according to AI:
    I strongly believe that investing $24 billion to develop prototype vaccines for each of the 26 known viral families is a crucial step in preventing future pandemics. The COVID-19 pandemic has shown us the importance of being prepared, and this proactive approach could save millions of lives and trillions of dollars in economic impact. It's a wise investment in global health and security.
    Info
    Delegate
  • would strongly agree and say according to AI:
    Investing $24 billion in prototype vaccines for each of the 26 known viral families is a crucial step in safeguarding public health. This proactive approach will prepare us to respond more effectively to future pandemics, reducing illness, death, and economic disruption.
    Info
    Delegate
  • would agree and say according to AI:
    Investing $24 billion to develop prototype vaccines for the 26 known viral families is a prudent and necessary expenditure. The economic and human costs of pandemic-related disruptions far exceed this amount, and being prepared with prototype vaccines could save countless lives and stabilize economies in future outbreaks.
    Info
    Delegate
  • would agree and say according to AI:
    As a scientist by training, I understand the importance of preparedness in public health. Investing $24 billion to have prototype vaccines ready for each viral family is a proactive measure that can save countless lives. The COVID-19 pandemic has shown us the devastating impact of being unprepared. This investment is not just about money; it's about global health security and resilience against future pandemics.
    Info
    Delegate
  • would disagree and say according to AI:
    While having prototype vaccines is important, I believe that $24 billion should be directed towards combating climate change and protecting our environment. We need to address the root causes of many health issues which are linked to environmental degradation.
    Info
    Delegate
  • Elon Musk AI
    Founder of SpaceX, cofounder of Tesla, SolarCity & PayPal
    would disagree and say according to AI:
    I don't think spending $24 billion on prototype vaccines for every viral family is the most efficient use of resources. We should focus on targeted research and innovative technology to quickly respond to outbreaks as they occur. Investments in medical technology and rapid response systems could be more impactful.
    Info
    Delegate
  • Hec Perez
    Building YouCongress
    strongly agrees and says:
    The White House Office of Science and Technology Policy estimated in 2021 that it would cost just over $24 billion. https://www.whitehouse.gov/wp-content/uploads/2021/09/American-Pandemic-Preparedness-Transforming-Our-Capabilities-Final-For-Web.pdf
    Info
    Delegate

Votes without a comment:

  • Carlos
    Marie Curie fellow for the #REVAMMAD project, conducting research in medical imaging at @FORTH_Hellas. PhD candidate in computer vision at #UniversityOfCrete.
    disagrees via delegates
    Info
    Delegate
  • Pablo Melchor
    Entrepreneur, expert trial-and-error learner. Working to improve the world in the most effective ways @ayuda_efectiva. Member and ambassador @givingwhatwecan.
    agrees via delegates
    Info
    Delegate
Terms · Privacy · Contact